| 000 | 01856 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517151411.0 | ||
| 264 | 0 | _c20170905 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1873-7064 | ||
| 024 | 7 |
_a10.1016/j.neuropharm.2017.04.029 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDi Cesare Mannelli, Lorenzo | |
| 245 | 0 | 0 |
_aEffects of natural and synthetic isothiocyanate-based H _h[electronic resource] |
| 260 |
_bNeuropharmacology _cJul 2017 |
||
| 300 |
_a49-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnthracenes _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtoxicity |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 | _aCricetulus |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aHydrogen Sulfide _xmetabolism |
| 650 | 0 | 4 |
_aHyperalgesia _xdrug therapy |
| 650 | 0 | 4 |
_aIsothiocyanates _xchemical synthesis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMorpholines _xtherapeutic use |
| 650 | 0 | 4 |
_aNeuralgia _xchemically induced |
| 650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aPaclitaxel _xtoxicity |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aPotassium Channel Blockers |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aLucarini, Elena | |
| 700 | 1 | _aMicheli, Laura | |
| 700 | 1 | _aMosca, Ilaria | |
| 700 | 1 | _aAmbrosino, Paolo | |
| 700 | 1 | _aSoldovieri, Maria Virginia | |
| 700 | 1 | _aMartelli, Alma | |
| 700 | 1 | _aTestai, Lara | |
| 700 | 1 | _aTaglialatela, Maurizio | |
| 700 | 1 | _aCalderone, Vincenzo | |
| 700 | 1 | _aGhelardini, Carla | |
| 773 | 0 |
_tNeuropharmacology _gvol. 121 _gp. 49-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2017.04.029 _zAvailable from publisher's website |
| 999 |
_c27102733 _d27102733 |
||